Medtronic plc
Income Statement
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.76B | $9.81B | $9.02B | $8.96B | $8.58B | $8.93B | $8.29B | $8.40B |
| Cost of Revenue | $3.42B | $3.40B | $3.26B | $3.06B | $3.00B | $3.15B | $2.78B | $2.95B |
| Gross Profit | $6.34B | $6.41B | $5.76B | $5.90B | $5.58B | $5.78B | $5.51B | $5.46B |
| Gross Margin | 65.0% | 65.4% | 63.8% | 65.8% | 65.0% | 64.8% | 66.5% | 64.9% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.20B | $3.06B | $2.96B | $2.97B | $2.81B | $2.72B | $2.72B | $2.76B |
| Operating Income | $1.76B | $1.87B | $1.46B | $1.69B | $1.45B | $1.44B | $1.65B | $1.60B |
| Operating Margin | 18.1% | 19.1% | 16.2% | 18.8% | 16.8% | 16.1% | 19.9% | 19.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $1.77B | $1.83B | $1.40B | $1.60B | $1.30B | $1.26B | $1.54B | $1.56B |
| Income Tax Expense | $289.0M | $575.0M | $254.0M | $215.0M | $255.0M | $198.0M | $237.0M | $281.0M |
| Net Income | $1.47B | $1.24B | $1.14B | $1.37B | $1.04B | $1.06B | $1.29B | $1.27B |
| Net Margin | 15.1% | 12.7% | 12.7% | 15.3% | 12.1% | 11.8% | 15.6% | 15.1% |
| EPS (Basic) | $1.15 | $0.98 | $0.89 | $1.07 | $0.81 | $0.82 | $1.01 | $0.99 |
| EPS (Diluted) | $1.14 | $0.96 | $0.89 | $1.07 | $0.81 | $0.81 | $1.01 | $0.99 |
| Shares Outstanding (Basic) | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.29B | 1.28B | 1.28B |
| Shares Outstanding (Diluted) | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B |
| Dividends Per Share | $0.72 | $0.71 | $0.71 | $0.71 | $0.71 | $0.70 | $0.70 | $0.70 |